二十年的抗动脉样硬化疫苗开发工作
Miguel A Moreno-Gonzalez1,2, Oscar A Ortega-Rivera1,2, Nicole F Steinmetz1,2,3,4,5,6
1Department of NanoEngineering, University of California-San Diego, La Jolla, CA 92039, USA.
Nano today
|October 20, 2023
概括
抗原特异性疫苗接种对预防慢性炎症性疾病 - - 动脉样硬化有很大的希望. 研究表明,向特定蛋白质可以减少斑块大小和胆固醇,提供一种新的心血管疾病策略.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管医学 心血管医学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 动脉样硬化是一种免疫媒介的炎症性疾病,导致动脉斑块,增加中风和心脏病发作的风险.
- 目前的治疗重点是生活方式,他类药物和免疫疗法,对疫苗的关注有限.
- 动脉样硬化的免疫反应包括保护性和有害的先天性和适应性免疫.
研究的目的:
- 审查抗原特异性疫苗接种作为动脉样硬化预防策略的潜力.
- 探索20多年来在动脉样硬化疫苗开发方面的研究和创新.
主要方法:
- 审查针对动脉样硬化相关的特定蛋白质的疫苗接种策略的研究.
- 通过氧化低密度脂蛋白 (LDL),阿波利波蛋白B-100,PCSK9,CETP,HSP60和HSP65.5对免疫的检查研究.
主要成果:
- 用或为目标蛋白进行免疫接种会诱导T细胞激活和抗原特异性抗体.
- 疫苗接种已证明可以减少动脉样硬化病变的大小和/或血清胆固醇水平.
- 研究强调了在动脉样硬化中准特定抗原的治疗潜力.
结论:
- 抗原特异性疫苗接种代表了动脉样硬化的一种新型预防策略.
- 这种方法可能会对全球心血管疾病负担产生重大影响.
- 进一步开发动脉样硬化疫苗是有必要的,以对抗这一主要死亡原因.
相关概念视频
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
11
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
11
Atherosclerosis IV: Nursing Management
17
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
17
Coronary Artery Disease IV: Preventive Measures
23
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12


